We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
85 hedge funds and large institutions have $202M invested in Corvus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 8
150% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $10.1M
37% more funds holding
Funds holding: 62 → 85 (+23)
27% more capital invested
Capital invested by funds: $159M → $202M (+$43.3M)
10.72% more ownership
Funds ownership: 48% → 58.72% (+11%)
Holders
85
Holders Change
+23
Holders Change %
+37.1%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
32
Increased
30
Reduced
12
Closed
8
Calls
$15.5M
Puts
$10.1M
Net Calls
+$5.36M
Net Calls Change
-$178K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$20M |
| 2 |
SC
Samlyn Capital
New York
|
+$16M |
| 3 |
DM
Deerfield Management
New York
|
+$7.47M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.94M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$5.5M |
